Trilogy Education and Rice University have joined forces for a new program. Photo courtesy of Rice University

As Rice University's campus continues to welcome back its students for a new year, the administration has big news about a new, innovative program to share.

Rice University's Glasscock School of Continuing Studies has partnered with New York-based workforce accelerator, Trilogy Education, to provide the first fintech boot camp on a college campus, according to a representative from the company.

"Technology skills are becoming foundational for many roles in the finance, energy and life science sectors," says David Vassar, assistant dean of professional and executive programs at the Glasscock School, in a news release. "We have partnered with Trilogy Education to bring to market a boot camp that prepares students to use their technical skills in a wide variety of fintech applications, from robo-advising to cryptocurrency. Whether you are already in finance or are looking for a way to transition into the industry, this program will prepare you to build a meaningful career in the fast-moving world of fintech."

Rice University FinTech Boot Camp is a 24-week program, and the inaugural class began in July. Enrollment for the next round is open from now until November 18. The program will provide students with core coding languages and technical tools that are crucial in the industry as well as pertinent technologies like machine learning and cryptocurrency. The participants will also have career-planning services and will receive a Certificate in Financial Technology from Rice.

The financial industry is booming in Houston, per the release, and companies are in competition for trained talent. Institutions like U.S. Bancorp and JPMorgan Chase have more coding positions open than Apple and Google, the release reveals, and according to data from Burning Glass, the country has added over 1.5 million fintech jobs in the past 8 years.

"The Rice University FinTech Boot Camp comes at a critical moment of need as the city of Houston transforms itself into a national hub for enterprise technology," says Robert Bruce, dean of the Glasscock School, in the release. "We've seen several fintech companies choose Houston to open new office locations and a rising demand from our longstanding industries like energy and manufacturing to transform themselves into technology and data-driven businesses."

Last year, the school launched its first boot camp in partnership with Trilogy. The Rice University Data Analytics Boot Camp has recently grown to expand to a new location in the Energy Corridor, the release states.

"Rice University's Glasscock School of Continuing Studies is playing an important role in building the digitally skilled workforce that Houston needs to support a growing innovation economy," says Dan Sommer, CEO and founder of Trilogy Education, in the release. "The Rice University FinTech Boot Camp will help working adults in Houston capitalize on the exploding demand for technology and data skills and spur additional investment in fintech throughout the region."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Austin company to bring AI-powered school to The Woodlands

AI education

Austin-based Alpha School, which operates AI-powered private schools, is opening its first Houston-area location in The Woodlands.

The 8,000-square-foot school, scheduled to be ready for the 2026-27 academic year, initially will serve students in kindergarten through eighth grade. Alpha says the school will offer “open workshop spaces and innovative classrooms that support personalized instruction, core academics, leadership development, and real-world life skills.”

Alpha sets aside two hours each school day for the AI-driven, self-paced study of core subjects like math, reading and science. The rest of each school day consists of life-skills workshops focusing on topics such as leadership and financial literacy.

Alpha’s school in The Woodlands has begun accepting applications for the 2026-27 school year. Annual tuition costs $40,000.

“The Woodlands is one of the most dynamic, forward-thinking communities in Texas, and Alpha is proud to bring

an innovative educational model that complements its strong academic foundation,” says Rachel Goodlad, head

of expansion for Alpha.

Founded in 2014, Alpha School combines adaptive technology-driven instruction with immersive life-skills workshops. Its model emphasizes mastery-based learning in core subjects alongside development of communication, critical thinking, financial literacy and leadership skills. It operates more than 15 schools across the country.

Elsewhere in Texas, Alpha operates schools in Austin, Brownsville, Fort Worth and Plano. Alpha also operates 12 Texas Sports Academy campuses in Texas, including locations in Houston, Pearland and Richmond, along with a NextGen Academy esports school in Austin, a school for gifted students in Georgetown, and lower-cost Nova Academy campuses in Austin and Bastrop.

Alpha has fans and critics. While supporters tout students’ high achievement rates, detractors complain about the high tuition and the AI-influenced depersonalization of education.

“Students and our country need to be in relationship with other human beings,” Randi Weingarten, president of the American Federation of Teachers, a teachers union, tells The New York Times. “When you have a school that is strictly AI, it is violating that core precept of the human endeavor and of education.”

Alpha co-founder MacKenzie Price, a podcaster and social media influencer, doesn’t share Weingarten’s views.

“Parents and teachers: We need to embrace this change,” Price wrote after President Trump signed an executive order promoting AI in schools.

The Times notes that Alpha doesn’t employ AI as a tutor or a supplement. Rather, the newspaper says, AI is “the school’s primary educational driver to move students through academic content.”

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”